Join to View Full Profile
1500 E. Duarte RdDuarte, CA 91010
Dr. Khan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Niloufer Khan is an Oncologist, specializing in Cutaneous Lymphoma and Hematologic Oncology, based in Duarte, CA. She completed her medical education and research fellowship at prestigious institutions such as the University of Chicago and Memorial Sloan Kettering Cancer Center. She currently works as a Physician at the City of Hope and has prior experience from Memorial Sloan-Kettering Cancer Center. Dr. Khan's areas of expertise include various types of lymphoma and health disparities, focusing on adolescent and young adult cancer. She has authored multiple medical publications and been involved in clinical trials. She's received significant recognition for her work, including the Young Investigator Award from the Conquer Cancer Foundation/American Society of Clinical Oncology.
Education & Training
Weill Cornell Graduate School of Medical SciencesMS, Clinical Epidemiology and Health Services Research, 2018 - 2020
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2016 - 2019
University of ChicagoResidency, Internal Medicine/Pediatrics, 2012 - 2016
Case Western Reserve University School of MedicineClass of 2012, M.D., Alpha Omega Alpha, Honors and Distinction in Research- Case Western Reserve UniversityB.A., Major: Biology/ International Studies; Minor: Spanish and Chemistry, 2004 - 2008
Certifications & Licensure
FL State Medical License 2022 - Present
CA State Medical License 2023 - 2027
NJ State Medical License 2021 - 2023
NY State Medical License 2016 - 2023
IL State Medical License 2015 - 2016
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Chief Hematology Fellow Memorial Sloan Kettering Cancer Center, 2018-2019
- Young Investigator Award Conquer Cancer Foundation/American Society of Clinical Oncology, 2017
- Alpha Omega Alpha, Honor Society Case Western Reserve University SOM, 2012
- Join now to see all
Clinical Trials
- A Phase 2 Multicenter Study of High Dose Chemotherapy With Autologous Stem Cell Transplant Followed by Maintenance Therapy With Romidepsin for the Treatment of T Cell Non-Hodgkin Lymphoma Start of enrollment: 2013 Jul 16
- Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients Start of enrollment: 2018 Jul 03
Publications & Presentations
PubMed
- Novel devimistat results in complete remissions in heavily pretreated Burkitt lymphoma in a phase 2 trial.Raphael Steiner, Liana Nikolaenko, Ranjit Nair, Venkatraman Seshan, Swetha Kambhampati Thiruvengadam
Blood Advances. 2025-11-11 - Maintenance therapy with romidepsin after autologous stem-cell transplant for peripheral T-cell lymphoma.Niloufer Khan, Parastoo B Dahi, Farhad Khimani, Andrei R Shustov, Mazyar Shadman
Blood Advances. 2025-09-23 - HSR25-181: Assessment of Content Validity of the Functional Assessment of Cancer Therapy - Cutaneous T-Cell Lymphoma (FACT-CTCL).Caroline Raymundo, Niloufer Khan, Kevin Molloy, Julia Scarisbrick, Susan Thornton
Journal of the National Comprehensive Cancer Network. 2025-03-28
Abstracts/Posters
- Current Selection Patterns, Toxicities and Outcomes of Pre-Transplant Salvage Treatment Regimens in Patients with Relapsed/Refractory Hodgkin Lymphoma: Results of a Mu...Niloufer Khan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Erythrocytosis associated with exogenous testosterone replacement.Khan N, Rossi-Foulkes, R, ACP Illinois Northern Residents’ and Medical Students’ Day, Chicago, IL, 1/21/2015
- Efficacy of single-agent decitabine in relapsed and primary refractory AML.Hantel A, Khan N, Larson RA, Godley LA, Thirman MJ, Artz A, Odenike O, Liu H, Churpek JE, King D, Rich E, Choi KJ, Knoebel RW, Stock W, American Society of Hematology, Orlando, FL, 1/6/2015
- Join now to see all
Press Mentions
Lymphoma Research Foundation Funds 29 Grants Investigating Lymphoma and Chronic Lymphocytic Leukemia, Introduces Expanded Research Program and Health Equity InitiativeMarch 31st, 2021
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
